Cell Therapies and Encapsulation Technologies Market is projected to be over USD 3.7 billion by 2030 | Roots Analysis

Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well.

The USD 3.7 billion (by 2030) financial opportunity within the encapsulated Cell Therapies and Encapsulation Technologies Market has been analyzed across the following segments:

Type of licensing deal payment

• Upfront payment
• Milestone payment

Therapeutic area

• Metabolic disorder
• Neurological disorder
• Ophthalmic disorder
• Oncological disorder

Target disease indication

• Ataxia telangiectasia
• Breast cancer
• Diabetes
• Glaucoma
• Head and neck cancer
• Macular telangectasia
• Pancreatic cancer
• Parkinson's disease
• Retinitis pigmentosa

Type of encapsulation material used

• Alginate-based microcapsule
• Cellulose hydrogel
• Medical-grade plastic
• Red blood cell

Key geographical region

• North America
• Europe
• Asia-Pacific and rest of the world

Key Market Insights

• Presently, over 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the world
• Ongoing therapy development programs are evaluating different types of cells, encapsulated in a wide range of biocompatible materials, aiming to offer viable and effective treatment options for various diseases
• In fact, majority of the product candidates are being developed for the treatment of metabolic disorders, primarily diabetes; big pharma are driving a significant proportion of research and development activity
• Clinical research in this field is growing at a fast pace; encapsulated therapy products are evaluating a number of pre-marketing end points to validate safety / efficacy
• Over the years, more than 3,000 patents have been granted / filed related to cell encapsulation technologies, demonstrating the heightened pace of research in this domain
• Foreseeing a lucrative future, several private and public investors have made capital investments worth approximately USD 1 billion, across over 100 funding instances, since 2013
• Growth in partnership activity reflects the rising interest of stakeholders in this domain; over 70% of deals have been inked related to therapies for metabolic disorders, involving both international and indigenous parties
• An evaluation of more than 300+ stakeholders engaged in cell therapies domain reveals the presence of several likely strategic partners spread across different geographical regions
• The short term opportunity in this market is likely to be driven by licensing activity and will depend on the untapped potential of novel cell encapsulation technologies in different application areas
• As multiple mid-late stage encapsulated cell therapies get commercialized in near future across different regions, the long term opportunity is likely to be distributed across diverse indications and encapsulation materials
• The enormous potential of encapsulated cell-based therapies / devices in the treatment of chronic disorders has captured the interest of several stakeholders in the industry

The Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030 report features the following companies, which we identified to be key players in this domain:

• ALTuCELL
• Azellon Cell Therapeutics
• Beta-Cell
• Betalin Therapeutics
• CellProtect Biotechnology
• Diatranz Otsuka
• Encellin
• EryDel
• Gloriana Therapeutics
• Living Cell Technologies
• MaxiVAX
• Neurotech Pharmaceuticals
• PharmaCyte Biotech
• Semma Therapeutics
• Sernova

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]